Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||NOT KNOWN / UNK||- / -|
Administered by: Other Purchased by: ??
Symptoms: Acidosis, Blood lactic acid, Blood lactic acid increased, Confusional state, Death, Echocardiogram, Electrocardiogram ST segment elevation, Hemiparesis, Right ventricular enlargement
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes; Hypercholesterolaemia; Hypertension; Comments: Unsure if patient has had symptoms associated with COVID-19 Patient has not been tested/or has had an inconclusive test for COVID-19. Patient is not enrolled in clinical trial
Diagnostic Lab Data: Test Date: 20210107; Test Name: blood lactic acid; Result Unstructured Data: Test Result:increased; Test Date: 20210107; Test Name: Echocardiography; Result Unstructured Data: Test Result:normal left ventricle but large right ventricle; Test Date: 20210107; Test Name: Electrocardiogram ST segment elevation; Result Unstructured Data: Test Result:widespread and then inferolateral ST elevation
CDC 'Split Type': GBPFIZER INC2021031416
Write-up: Death unexplained; Electrocardiogram ST segment elevation; Hemiparesis/right-sided facial weakness; Confusional state; Acidosis/acidemia; high lactate/blood lactic acid increased; Right ventricular enlargement; This is a spontaneous report from a contactable physician. This is a report received from the Medicines and Healthcare products Regulatory Agency (MHRA). Regulatory authority report number GB-MHRA-WEBCOVID-20210107154410, Safety Report Unique Identifier GB-MHRA-ADR 24568917. An 85-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not known) via an unspecified route of administration on 05Jan2021 at a single dose for covid-19 immunization. Medical history included hypercholesterolaemia, hypertension and diabetes mellitus from unknown dates and unknown if ongoing, however fully active and mobile. Unsure if patient has had symptoms associated with COVID-19. Patient has not been tested/or has had an inconclusive test for COVID-19. Patient is not enrolled in clinical trial. The patient''s concomitant medications were not reported. Two days following vaccination she presented with widespread and then inferolateral ST elevation on ECG, hemiparesis and right-sided facial weakness, confusion state, high lactate/blood lactic acid increased and acidosis/acidemia. Echocardiography showed a normal left ventricle but large right ventricle. The differential was pulmonary embolism, intracranial haemorrhage/thrombosis and/or myocardial infarction. Unfortunately, she rapidly deteriorated and died. She has been referred to the coroner, so cause of death will hopefully be clarified. We are not referring as a definite side-effect, however, the temporal association and clinical findings, and after discussion with our lead pharmacist (and in my role as a medical examiner) we felt we should complete this as a possible reaction/complication. The patient died on 07Jan2021. The outcome of the events inferolateral ST elevation on ECG, hemiparesis and right-sided facial weakness, confusion state, high lactate/blood lactic acid increased and acidosis/acidemia was not recovered. No follow-up attempts are possible, information about batch number cannot be obtained.; Reported Cause(s) of Death: Death unexplained
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166